Correlation between several biological parameters and 5-year survival rate in patients with lung cancer

Chinese Journal of Clinical Rehabilitation

Volumn 10, Issue 28, 2006, Pages 67-69

  Rui, Meng ^a   Li, Long Yun ^b   Liu, Chang Ting ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; GLYCOPROTEIN P; MOLECULAR MARKER; PROTEIN P21; PROTEIN P53;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIFESPAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SMOKING; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

EID: 33747377767     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Haque AK, Syed S, Lele SM, et al. Immunohistochemical study of thyroid transcription factor-1 and HER2/neu in non-small cell lung cancer: strong thyroid transcription factor-1 expression predicts better survival. Appl Immunohistochem Mol Morphol 2002;10(2):103-9
2. Rostad H, Naalsund A, Strand TE, et, al. Results of pulmonary resection for lung cancer in Norway, patients older than 70 years. Eur J Cardiothorac Surg 2005;27(2):325-8
3. Xavier F, Henn LdA, Oliveira M, et al. Smoking and its relation to the histological type, survival, and prognosis among patients with primary lung cancer. Rev Paul Med 1996;114:1298-302
4. Ebina M, Steinberg SM, Mulshine JL et al. Relationship of p53 overexpression and up-regula-tion of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res 1994; 54(9): 2496-503
5. Nonaka M, Kadokura M, Yamamoto S, et al. Tumor dimension and prognosis in surgically treated lung cancer: for intentional limited resection. Am J Clin Oncol 2003;26(5):499-503
6. Iizasa T, Suzuki M, Yasufuku K, et al. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma. Ann Thorac Surg 2004;77(6):1896-902
7. Dworakowska D, Jassem E, Jassem J, et al. Prognostic relevance of altered pRb and p53 protein expression in surgically treated non-small cell lung cancer patients. Oncology 2004;67(1): 60-6
8. Chapelier A, Fadel E, Macchiarini P, et al. Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall. Eur J Cardiothorac Surg 2000;18(5): 513-8
9. Mitsudomi T, Hamajima N, Ogawa M, et al. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res 2000;6(10):4055-63
10. Endo K, Terada T. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. J Hepatol 2000; 32(1): 78-84
11. Del Principe MI, Del Poeta G, Maurillo L, et al. P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia. Br J Haematol 2003;121(5):730-8
12. Young-Chul K, Kyung-Ok P, Jeffrey A, et al. The interactive effect of Ras, HER2, p53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients. Lung Cancer 1998;42(2):163-70